These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33015772)

  • 1. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
    Chen AY; Zhang K; Liu GQ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
    Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4467-4476. PubMed ID: 30058678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
    Tan SF; Ni JX; Xiong H
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.
    Wang GF; Wen LN
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10410-10418. PubMed ID: 33155197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA WTAPP1 promotes proliferation of laryngeal carcinoma cells through regulating microRNA-592.
    Shi XY; Lin JJ; Ge XJ; Shi Y
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9532-9540. PubMed ID: 33015795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-30a-3p inhibits malignant progression of hepatocellular carcinoma through regulating IGF1.
    Wei YY; Ren TL
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12144-12152. PubMed ID: 33336732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
    Ma CX; Gao WC; Tian L
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
    Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA XIST promotes migration of Wilms' tumor cells through modulation of microRNA-193a-5p.
    Yao FZ; He R; Jiang YC; Hou Y; Qian D
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9889-9898. PubMed ID: 33090392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircRNA_100876 promote proliferation and metastasis of breast cancer cells through adsorbing microRNA-361-3p in a sponge form.
    Yang CY; Zhang FX; He JN; Wang SQ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6962-6970. PubMed ID: 31486496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
    Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9.
    Wu Y; Wu Y; Chen XY; Niu YX; Lv FZ; Gao W
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8893-8901. PubMed ID: 32964979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
    Yu XY; Tian JR; Yang D; Tan HR
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-136-5p regulates gemcitabine resistance in pancreatic cancer via down-regulating ZNF32.
    Xu Y; Qin Y; Cui JX; Xu J
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10472-10482. PubMed ID: 33155203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
    Li Y; Zhou HC; Zhang Y; Huang H
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
    Feng F; Chen AP; Wang XL; Wu GL
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5310-5319. PubMed ID: 32495864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p.
    Xue MY; Cao HX
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3724-3733. PubMed ID: 32329849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
    Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.